Lung Cancer in Italy - In Italian: Dr. Marina Garissino and Dr. Silvia Novello
In this special Italian-language edition of Lung Cancer Considered, host Dr. Alfredo Addeo examines lung cancer in Italy with Dr. Marina Garissino and Dr. Silvia Novello. The researchers discuss thei...
30 Juni 202155min
Financial Toxicity with Dr. Fumiko Chino
In this edition of Lung Cancer Considered, host Narjust Duma and Dr. Fumiko Chino discuss a challenge to thoracic oncology which is financial toxicity associated with cancer care. The two women dive ...
15 Juni 202140min
ASCO 2021 Highlights with Dr. Heather Wakelee and Dr. Alfredo Addeo
The American Society of Clinical Oncology meeting just concluded and Lung Cancer Considered has a summary of the meeting, with a unique lung cancer focus. Tune in as host Stephen Liu and guests Dr. A...
10 Juni 202153min
Neoadjuvant IO with Patrick Forde and Leah Backhus
In this edition of Lung Cancer Considered, host Dr. Narjust Duma discusses the use of neoadjuvant immunotherapy, through a multidisciplinary lens, with guests Dr. Leah Backhus and Dr. Patrick Forde.
7 Juni 202139min
FDA with Dr. Harpreet Singh
In this episode of Lung Cancer Considered, Dr. Stephen Liu sits down with guest Dr. Harpreet Singh from the FDA to discuss the agency’s oncology drug approval process. The interview also covers how n...
1 Juni 202137min
Virtual Tumor Board: NSCLC - Higgins and Calles
In this episode of Lung Cancer Considered, guests Dr. Kristin A. Higgins and Dr. Antonio Calles discuss the case of a 42-year-old woman who presents to the emergency room with right shoulder pain and ...
17 Maj 202146min
Seminal Trials Series - KEYNOTE 001 with Dr Edward Garon and Cary Parton: Patient Input
This new episode of Lung Cancer Considered features a discussion of the seminal trial KEYNOTE 001 and how it impacted research and clinical care for patients with lung cancer. This podcast is notewor...
11 Maj 202147min
KRAS G12C Mutation with Dr. Tetsuya Mitsudomi
This episode of Lung Cancer Considered covers recent promising results with new targeted agents for NSCLC harboring a KRAS G12C mutation. Thoracic oncologists have long thought this condition was undr...
3 Maj 202133min
